Shattuck Labs, Inc. (STTK)
5.59
-0.06
(-1.15%)
USD |
NASDAQ |
Oct 08, 11:31
Shattuck Labs Total Assets (Quarterly) : 220.67M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 220.67M |
| March 31, 2026 | 102.12M |
| December 31, 2025 | 91.03M |
| September 30, 2025 | 100.33M |
| June 30, 2025 | 64.37M |
| March 31, 2025 | 77.17M |
| December 31, 2024 | 92.24M |
| September 30, 2024 | 111.72M |
| June 30, 2024 | 128.61M |
| March 31, 2024 | 146.34M |
| December 31, 2023 | 159.56M |
| September 30, 2023 | 130.46M |
| June 30, 2023 | 155.27M |
| March 31, 2023 | 177.68M |
| Date | Value |
|---|---|
| December 31, 2022 | 205.32M |
| September 30, 2022 | 222.94M |
| June 30, 2022 | 251.34M |
| March 31, 2022 | 270.49M |
| December 31, 2021 | 298.58M |
| September 30, 2021 | 310.57M |
| June 30, 2021 | 323.78M |
| March 31, 2021 | 336.85M |
| December 31, 2020 | 348.99M |
| September 30, 2020 | 144.86M |
| June 30, 2020 | 155.54M |
| March 31, 2020 | |
| December 31, 2019 | 44.97M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
| Biogen, Inc. | 32.09B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.531M |
| Shareholders Equity (Quarterly) | 211.14M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 27.59 |
| Net Debt Paydown Yield | 0.01% |